About
0.73USD+0.02 +3.00%
Closed • Updated at 13:17 GMT+00:00Market Cap$58.10M
Volume420.0K
Beta1.22
RSI37.12
Scynexis, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 22 2026
SCYNEXIS Announces One-for-Eight Reverse Stock Split
May 11 2026
SCYNEXIS Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 7 2026
SCYNEXIS Announces Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Mar 31 2026
SCYNEXIS Announces $40.0 Million Private Placement
Mar 31 2026
SCYNEXIS Completes Transformative Acquisition of PXL-770, an innovative, highly selective, direct AMPK activator for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Recent Videos

Cómo invertir en Scynexis Inc (SCYX) paso a paso
Apr 03, 2026

SCYNEXIS 2026 Corporate Update Call | Completes Transformative Acquisition of PXL-770 | March 31
Apr 01, 2026

Biotech Spotlight: SCYNEXIS, Inc. (SCYX)
Apr 12, 2025

SCYNEXIS: Recall, Lawsuits, and a Billion-Dollar Deal on Hold
Mar 13, 2025
Community Chat
Ask AI
Try asking
Google Übersetzer